In addition to the weight loss effect, it has been shown to improve various risk factors, such as blood pressure, dyslipidemia, and blood glucose levels, which are closely related to obesity
When to Pause, Continue, or Adjust Your Medication During Acute Illness The decision to pause semaglutide during COVID-19 depends entirely on your symptom severity, hydration capacity, and individual clinical profile
Use an insulated medical travel case with ice packs
The pattern is consistent: diarrhea peaks during the first 48 weeks at each new dose level, resolves as GLP-1 and GIP receptors in the gut downregulate, and rarely persists beyond the titration phase
Patients on sustained GLP-1 therapy should monitor their intake of all micronutrients, not just vitamin D, to prevent deficiency over time